Heterogeneity of treatment effects of glucose-lowering drug classes for type 2 diabetes: LEGEND-T2DM network real-world evidence

Related articles

1. Analysis of the current status of SGLT-2i and GLP-1RA in patients with diabetes complicated with coronary heart disease

   This article has 7 authors:

   1. Fang Wang
   2. junyi Zhang
   3. Jianqiang Zhu
   4. Jianwei Xiao
   5. Xingyue Liao
   6. Ying Yang
   7. Pan Du

2. Therapeutic Outcomes of Metformin Alone Versus Metformin Plus Saxagliptin in Newly Diagnosed Type 2 Diabetes

   This article has 1 author:

   1. Dhafer Rahman Abed Al-janabi

3. Comparative Effectiveness of GLP-1 Receptor Agonists Versus Metformin in Reducing Dementia Risk Among Adults ≥65 Years with Type 2 Diabetes Mellitus and Delirium: A 20-Year Real-World Data Analysis (2005–2025)

   This article has 5 authors:

   1. Francisco Mercado
   2. Sumi Akter
   3. Aoi Ogawa
   4. Subrahmanyan Valadi Ramakrishnan
   5. Reannon Suzuki